Nasdaq

Medtronic Announces FDA Approval for MiniMed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...
PC Magazine

FDA Approves Automated Insulin System for Young Kids

The MiniMed 770G was approved for kids aged 2 to 6. It will monitor their sugar levels and automatically adjust insulin with little or no input required. Type 1 diabetes patients need to monitor their ...
Medscape

FDA OKs New 'Artificial Pancreas' Medtronic 770G

The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...
MobiHealthNews

Medtronic's MiniMed 770G scores FDA clearance for kids, adults

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...
KOIN 6

Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes

DUBLIN, Oct. 18, 2022 /PRNewswire/ -- Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G ...